Total Payments
$258,808
2024 Payments
$14,735
Companies
26
Transactions
248
Medicare Patients
1,633
Medicare Billing
$335,606
Payment Breakdown by Category
Consulting$156,267 (60.4%)
Other$56,707 (21.9%)
Travel$36,744 (14.2%)
Food & Beverage$8,976 (3.5%)
Research$113.07 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $156,267 | 65 | 60.4% |
| Travel and Lodging | $36,744 | 36 | 14.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,910 | 9 | 13.5% |
| Honoraria | $19,513 | 6 | 7.5% |
| Food and Beverage | $8,976 | 129 | 3.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,200 | 1 | 0.9% |
| Unspecified | $113.07 | 1 | 0.0% |
| Grant | $84.20 | 1 | 0.0% |
Payments by Type
General
$258,695
247 transactions
Research
$113.07
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $63,614 | 57 | $0 (2024) |
| PFIZER INC. | $46,709 | 30 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $32,207 | 27 | $0 (2023) |
| Janssen Global Services, LLC | $26,171 | 15 | $0 (2020) |
| Janssen Biotech, Inc. | $19,543 | 35 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $15,578 | 14 | $0 (2024) |
| West-Ward Pharmaceuticals | $12,135 | 4 | $0 (2018) |
| GENZYME CORPORATION | $9,896 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $7,820 | 11 | $0 (2024) |
| Legend Biotech USA Inc. | $7,425 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,735 | 28 | GENZYME CORPORATION ($9,500) |
| 2023 | $71,416 | 62 | PFIZER INC. ($22,093) |
| 2022 | $35,096 | 44 | E.R. Squibb & Sons, L.L.C. ($16,853) |
| 2021 | $35,144 | 19 | PFIZER INC. ($17,013) |
| 2020 | $11,175 | 5 | Celgene Corporation ($7,145) |
| 2019 | $37,849 | 42 | Celgene Corporation ($16,235) |
| 2018 | $40,128 | 36 | West-Ward Pharmaceuticals ($10,605) |
| 2017 | $13,265 | 12 | Celgene Corporation ($7,348) |
All Payment Transactions
248 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $119.92 | General |
| Category: Oncology | ||||||
| 12/08/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $57.67 | General |
| Category: Oncology | ||||||
| 12/07/2024 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,979.00 | General |
| 12/07/2024 | Janssen Biotech, Inc. | TALVEY (Biological), TECVAYLI, DARZALEX | Food and Beverage | In-kind items and services | $139.33 | General |
| Category: Oncology | ||||||
| 12/06/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $84.10 | General |
| 12/05/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $73.73 | General |
| 11/14/2024 | Celgene Corporation | — | Travel and Lodging | Cash or cash equivalent | $425.53 | General |
| 10/26/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $44.72 | General |
| 09/07/2024 | Janssen Scientific Affairs, LLC | CARVYKTI (Drug), DARZALEX | Food and Beverage | In-kind items and services | $36.14 | General |
| Category: Oncology | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $99.91 | General |
| 09/05/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $89.78 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $26.98 | General |
| 07/25/2024 | Celgene Corporation | ABECMA (Biological) | Food and Beverage | Cash or cash equivalent | $11.99 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $105.21 | General |
| Category: Oncology | ||||||
| 06/10/2024 | Legend Biotech USA Inc. | — | Travel and Lodging | In-kind items and services | $25.50 | General |
| 06/10/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $6.75 | General |
| 06/10/2024 | Legend Biotech USA Inc. | — | Travel and Lodging | In-kind items and services | $4.65 | General |
| 05/23/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,493.00 | General |
| 05/20/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $136.00 | General |
| Category: Oncology | ||||||
| 05/16/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $86.81 | General |
| 05/06/2024 | AstraZeneca Pharmaceuticals LP | LUMOXITI (Biological) | Consulting Fee | Cash or cash equivalent | $342.50 | General |
| Category: Oncology | ||||||
| 02/23/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $23.82 | General |
| 02/07/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $84.65 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple Myeloma | ABBVIE INC. | $113.07 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 384 | 732 | $300,422 | $71,216 |
| 2022 | 8 | 447 | 1,032 | $437,841 | $106,492 |
| 2021 | 8 | 362 | 807 | $345,304 | $87,667 |
| 2020 | 8 | 440 | 901 | $295,650 | $70,231 |
Total Patients
1,633
Total Services
3,472
Medicare Billing
$335,606
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 155 | 359 | $190,806 | $39,120 | 20.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 163 | $46,509 | $15,309 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 69 | 83 | $22,226 | $6,293 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $10,627 | $2,576 | 24.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $10,191 | $2,287 | 22.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 39 | 45 | $7,743 | $2,267 | 29.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 19 | 19 | $6,192 | $1,585 | 25.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 13 | 14 | $3,708 | $1,093 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 14 | $2,420 | $685.26 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 193 | 585 | $299,808 | $66,653 | 22.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 239 | $67,637 | $19,509 | 28.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 32 | $18,130 | $5,083 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 57 | 59 | $14,952 | $4,673 | 31.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 29 | 29 | $15,604 | $4,330 | 27.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 37 | 38 | $11,662 | $3,118 | 26.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 17 | 21 | $5,315 | $1,645 | 31.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 22 | 29 | $4,733 | $1,481 | 31.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 184 | 532 | $263,406 | $63,593 | 24.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 123 | $34,809 | $10,417 | 29.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 20 | $10,635 | $3,284 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 43 | 47 | $11,410 | $3,101 | 27.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 17 | 17 | $9,188 | $2,242 | 24.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 23 | 23 | $6,679 | $2,008 | 30.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 20 | 24 | $5,835 | $1,944 | 33.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 19 | 21 | $3,342 | $1,079 | 32.3% |
About Dr. Krina Patel, M.D
Dr. Krina Patel, M.D is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2010. The National Provider Identifier (NPI) number assigned to this provider is 1104142405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Krina Patel, M.D has received a total of $258,808 in payments from pharmaceutical and medical device companies, with $14,735 received in 2024. These payments were reported across 248 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($156,267).
As a Medicare-enrolled provider, Patel has provided services to 1,633 Medicare beneficiaries, totaling 3,472 services with total Medicare billing of $335,606. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Houston, TX
- Active Since 04/12/2010
- Last Updated 07/17/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104142405
Products in Payments
- DARZALEX (Biological) $38,539
- CARVYKTI (Drug) $12,567
- Oncology TA (Drug) $12,135
- ELREXFIO (Drug) $8,313
- CARVYKTI (Biological) $7,048
- Revlimid (Drug) $6,451
- Kyprolis (Biological) $4,447
- ABECMA (Biological) $3,860
- Tecartus (Drug) $3,320
- EMPLICITI (Biological) $3,166
- Pomalyst (Drug) $2,812
- OPDIVO (Biological) $2,740
- DARZALEX (Drug) $2,392
- ICLUSIG (Drug) $2,290
- XPOVIO (Drug) $2,227
- LUMOXITI (Biological) $342.50
- SARCLISA (Biological) $339.68
- CALQUENCE (Drug) $254.92
- BLENREP (Biological) $232.88
- VENCLEXTA (Drug) $199.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Internal Medicine $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Internal Medicine $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
Internal Medicine $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947
Internal Medicine $786,947